On Aug. 10, the FDA dominated to reject copyright for assisted psychotherapy for PTSD, citing insufficient proof and the need for more research. The ruling is in step with a letter APA sent the FDA before this 12 months that stated that a review of the literature on copyright-assisted psychotherapy by a multidisciplinary panel of gurus determined t